This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. (MRNA) inched 0.15% higher to $118.25 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.51% to 10,575.62 and Dow Jones Industrial Average falling 1.71% to 28,725.51. The stock's rise snapped a two-day losing streak. Moderna Inc. closed $258.40 short of its 52-week high ($376.65), which the company achieved on November 29th.
The stock outperformed some of its competitors Friday, as AbbVie Inc. (ABBV) fell 5.96% to $134.21, Amgen Inc. (AMGN) fell 1.32% to $225.40, and AstraZeneca PLC ADR (AZN.LN) fell 0.13% to $54.84. Trading volume (3.8 M) remained 948,018 below its 50-day average volume of 4.8 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 30, 2022.
(END) Dow Jones Newswires
September 30, 2022 16:32 ET (20:32 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.